Does BREXPIPRAZOLE Cause Delusion? 72 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Delusion have been filed in association with BREXPIPRAZOLE (Rexulti). This represents 0.5% of all adverse event reports for BREXPIPRAZOLE.
72
Reports of Delusion with BREXPIPRAZOLE
0.5%
of all BREXPIPRAZOLE reports
1
Deaths
22
Hospitalizations
How Dangerous Is Delusion From BREXPIPRAZOLE?
Of the 72 reports, 1 (1.4%) resulted in death, 22 (30.6%) required hospitalization.
Is Delusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BREXPIPRAZOLE. However, 72 reports have been filed with the FAERS database.
What Other Side Effects Does BREXPIPRAZOLE Cause?
Weight increased (1,589)
Product use in unapproved indication (1,188)
Off label use (937)
Akathisia (807)
Drug ineffective (730)
Tardive dyskinesia (558)
Tremor (552)
Anxiety (475)
Product use issue (434)
Suicidal ideation (427)
What Other Drugs Cause Delusion?
PIMAVANSERIN (2,421)
ARIPIPRAZOLE (985)
OLANZAPINE (685)
CLOZAPINE (682)
QUETIAPINE (583)
RISPERIDONE (570)
CARBIDOPA\LEVODOPA (472)
PALIPERIDONE (472)
HALOPERIDOL (240)
SERTRALINE (234)
Which BREXPIPRAZOLE Alternatives Have Lower Delusion Risk?
BREXPIPRAZOLE vs BREXUCABTAGENE AUTOLEUCEL
BREXPIPRAZOLE vs BRIGATINIB
BREXPIPRAZOLE vs BRILINTA
BREXPIPRAZOLE vs BRILIQUE
BREXPIPRAZOLE vs BRIMONIDINE